multiple sclerosis and glp 1 Glucagon-like peptide-1 medicines in neurological psychiatric disorders: Cell Reports Medicine Full article: Targeting metabolic dysfunction

Comparing the effects of tofacitinib, methotrexate and the combination, on bone marrow oedema, synovitis and bone erosion in methotrexate-naive, early active rheumatoid arthritis: results of an exploratory randomised MRI study incorporating semiquantitative and quantitative techniques

That stomach acid can wear down tooth enamel fast

Retatrutide at 12mg produces 24.2% average weight loss over 48 weeks

The companys lead asset is in Phase 3 with decent phase 2 data

Oral is the future: healthcare providers believe that oral medications are the future of GLP-1 medications, with 78% reporting that they think the majority of patients will want to switch to an oral form once available